Prednisone Completed Phase 2 Trials for Multiple Myeloma and Plasma Cell Neoplasm Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003490Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
NCT00003554Rituximab in Treating Patients With Multiple Myeloma
NCT00006890Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma